Spotclav 625/Spotclav DS 312.5

Spotclav 625/Spotclav DS 312.5 Mechanism of Action

amoxicillin + clavulanic acid

Manufacturer:

Sparsh Bio-Tech

Distributor:

Khriz Pharma

Marketer:

Khriz Pharma
Full Prescribing Info
Action
Antibacterial (Penicillin).
In clinical trials Amoxicillin/Clavulanic acid is clinically and bacteriological superior to Amoxicillin alone. Clavulanic acid enhances the antibacterial spectrum of Amoxicillin by rendering most β-lactamase producing isolates susceptible to the drug. Clavulanic acid alone possesses only weak antibacterial activity, except against Legionella spp., and certain strains of Branhamella catarrhalis, B. fragilis and Neisseria gonorrhoeae. The in-vitro synergy of Clavulanic acid combined with Amoxicillin has been confirmed in vivo in numerous experimental infections in animals.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in